Arumakimig

Multispecific antibody

Also known as MAS825

Earlyevidence

Evidence outlook

Mid-stage studies underway, no completed readout

Phase 2 studies are registered but none has completed a readout, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (1)
Other / comorbidity
NCT06309823 · The Hospital for Sick Children
2023-02-08 – 2024-01-17 · X-linked Lymphoproliferative Syndrome Type 2 (XLP-2)
What this study did
Phase 2 (6)
Still's Disease
NCT07203001 · Novartis Pharmaceuticals
2025-11-03 – 2028-05-17 · Still´s Disease
What this study did
Other / comorbidity
NCT04641442 · Novartis Pharmaceuticals
2020-12-18 – 2032-11-23 · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations
What this study did
NCT07748624 · Novartis Pharmaceuticals
2026-10-30 – 2031-04-15 · VEXAS Syndrome
What this study did
NCT03827798 · Novartis Pharmaceuticals
2019-02-27 – 2026-09-11 · Hidradenitis Suppurativa
What this study did
NCT06097663 · Novartis Pharmaceuticals
2024-02-15 – 2024-11-04 · Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP)
What this study did
NCT04382651 · Novartis Pharmaceuticals
2020-06-11 – 2021-04-21 · COVID-19 Pneumonia, Impaired Respiratory Function
What this study did
Phase 1 (1)
Other / comorbidity
NCT04665154 · Novartis Pharmaceuticals
2019-06-07 – 2022-08-03 · Healthy Volunteers
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Arumakimig to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
April 2027 (1)
Phase 2Still's DiseaseRecruiting
Est. primary completion 2027-04-22 · NCT07203001 · CT.gov ↗
What to watch
2028 (1)
December 2028 (1)
Phase 2VEXAS SyndromeRecruiting
Est. primary completion 2028-12-26 · NCT07748624 · CT.gov ↗
What to watch

See the full readout calendar ↗